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The role of interleukin-4 as a regulator of immune
responses in the skin is investigated with regard to
the outcome of contact hypersensitivity reaction in
interleukin-4-deficient BALB/C mice. In previous
studies conflicting results were obtained concerning
the role of interleukin-4 in contact hypersensitivity
reactions supporting either a proinflammatory or
rather an inhibitory function of this cytokine. Interleu-
kin-4 deficient BALB/C mice sensitized to 2,4-
dinitrochlorobenzene showed after challenge a signi-
ficant reduction in magnitude and duration of the
contact hypersensitivity response in comparison with
wild-type mice. This attenuation was accompanied by
a significant reduction of edema and cellular infiltrates
in the dermis and a lacking induction of IL-10 mRNA
expression in skin. Also, adoptive transfer experiments
revealed that BALB/C mice failed to exhibit contact
hypersensitivity after injection of lymph node cells
Despite considerable progress in elucidating the natureof cellular interactions involved in contact hyper-sensitivity (CHS) reactions neither the role of par-ticular cytokines nor the role of T cell subsets(CD81 and CD41 T cells) are fully understood. In
vivo and in vitro antibody depletion studies from several laboratories
indicated CD41 T cells as the effector T cells in CHS whereas
others observed the ability of CD81 T cells to mediate CHS
(Miller and Jenkins, 1985; Gosinski and Tigelaar, 1990; Hauser,
1990; Gautam et al, 1991; Xu et al, 1996). The CHS response and
delayed-type hypersensitivity reaction are often regarded as Th1-
mediated processes, as it could be shown that T-helper 1 cells
[interleukin (IL)-2, interferon-γ producers] could passively transfer
these reactions (Cher and Mosmann, 1987; Dieli et al, 1994).
Studies aimed at defining the role of T-helper 2 cells (IL-4, IL-10
producer) provided evidence that these cells are inactive or may
even exert suppressive effects in CHS reactions (Cher and Mosman,
1987; Asada et al, 1997). Th2 cells, however, have also been shown
to be critically involved in inflammatory processes as, e.g., chronic
graft-versus-host reactions, autoimmune diseases and atopic derma-
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obtained from sensitized interleukin-4 deficient mice.
To examine further the role of the contact allergen
used to induce the contact hypersensitivity response,
mice were also sensitized and challenged with Oxazo-
lone. Here a similar magnitude and duration of contact
hypersensitivity in both the interleukin-4 deficient
mice and BALB/C control mice was observed. This
indicates that the contact hypersensitivity response to
2,4-dinitrochlorobenzene and Oxazolone may partly
evolve on different pathways being dependent and
independent of interleukin-4. Our results clearly show
that the complete loss of endogenous interleukin-4
expression in BALB/C mice is associated with an
impaired manifestation of contact hypersensitivity
response to 2,4-dinitrochlorobenzene, implying an
important proinflammatory function of this cytokine.
Key words: contact hypersensitivity/cytokine deficiency/skin/
transgenic mice. J Invest Dermatol 112:476–482, 1999
titis (Fanslow et al, 1991; Goldman et al, 1991; Van der Heijden
et al, 1991; Erb et al, 1997).
IL-4 is a pleiotropic cytokine product of Th2 cells regulating
immunoglobulin isotype switching (IgE, IgG4). Arguably, the most
important effect of IL-4 is its role in T cell growth, especially the
development of Th2 lineage. It harbors B-cell stimulating activities
and can suppress Th1-mediated immune responses (Mosmann and
Coffman, 1989; Mueller et al, 1997). It is well known that IL-4 is
produced in murine skin during the elicitation phase of CHS
(Asada et al, 1997), but whether it plays a proinflammatory or anti-
inflammatory part remains unclear. IL-4 has been reported to exert
negative regulatory effects on the CHS response as the injection
of recombinant IL-4 reduced the magnitude of the challenge
response to the hapten (Gautam et al, 1992). Furthermore, pretreat-
ment with monoclonal anti-IL-4 antibodies before challenge led
to increased ear swelling compared with mice pretreated with
isotype control monoclonal antibodies (Asada et al, 1997). Pro-
inflammatory activities of IL-4, however, were suggested from
experiments by Salerno et al (1995) using anti-IL-4 antibodies,
which markedly inhibited the manifestation of contact dermatitis
(CD) and the passive transfer of the CHS reaction by immune
lymph node cells.
Transgenic mouse technology has enormously advanced the
opportunities to study the role of a specific cytokine in CD as the
role of genes suspected to be involved in the pathogenesis of CD
can now be studied in mice characterized by an overexpression or
a loss of function of a particular gene. The IL-4-deficient mice,
generated by Ku¨hn et al (1991), show normal T cell and B
cell development, but strongly reduced levels of IgG1 and IgE.
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Moreover, independently generated IL-4-deficient mice (Kopf et al,
1993) indicated a requirement of IL-4 in the generation of
Th2-derived cytokines and an impairment of immune responses
dependent on these cytokines.
In order to define better the role of endogenous IL-4 in inducing
and regulating CHS we treated BALB/C mice lacking the IL-4
gene with two obligate contact sensitizing agents [2,4-dinitrochloro-
benzene (DNCB), Oxazolone] to investigate the CHS response in
the absence of IL-4.
MATERIALS AND METHODS
Mice Breeding pairs of the IL-4-deficient BALB/C mice were a kind
gift from Dr. W. Mu¨ller, Institute of Genetics, University of Cologne,
Germany. They were used in the tenth back-cross generation. Wild-type
littermates were purchased from Boongart, Sweden. Mice were bred and
kept in specific pathogen free status under standard diet. They were used
at 8–16 wk of age.
Induction and challenge of CHS Mice were sensitized topically with
100 µl of a 5% DNCB in an olive oil, acetone solution (1:4) on the ventral
unshaved abdomen. Five days later, 10 µl of a 1% DNCB olive oil, acetone
solution were each applied to both sides of the right ear. The left ear was
exposed to vehicle alone. For CHS to Oxazolone, the same concentrations
and vehicle was used for sensitization and challenge.
Measurements of ear thickness to determine the cutaneous manifestation
of CHS was performed by using a micrometer (Oditest, Kroeplin). The
area below the apex of the ear was measured leaving a barely perceptible
margin of ear visible above the edge of the measuring device. Ear swelling
was calculated by subtracting the prechallenge value from the postchallenge
value (Gad et al, 1986).
Histology For histologic examination mice were killed 24 h after
challenge. Ears were fixed in formalin (10%) for 1–3 d and processed for
paraffin embedding. Tissue sections (6 µm) were stained with hematoxylin
and eosin, mounted, and analyzed in a blinded fashion by two inde-
pendent observers.
Immunohistochemical staining Ears were obtained 12, 24, and 72 h
after challenge with DNCB. Ears were snap frozen in liquid nitrogen.
Alkaline phosphatase anti-alkaline phosphatase (APAAP) staining of cryosec-
tions was performed following established procedures. Rabbit anti-mouse
immunoglobulins and APAAP complexes were obtained from Dako
(Hamburg, Germany). The alkaline phosphatase reaction was demonstrated
by incubation in a solution containing Fast Red TR (1 mg per ml) and
naphtol AS-TR phosphate (0.2 mg per ml) (Sigma, St. Louis, MO).
Levamisole (0.24 mg per ml) was added to block endogenous alkaline
phosphatase activity. Monoclonal anti-mouse antibodies to ICAM-1, and
IA (major histocompatibility complex class II) were obtained from Dianova
(Hamburg, Germany). Negative controls consisted of the omission of
primary antibodies and staining with the dye alone. As a positive control
a polyclonal antibody directed against keratin was used. The stained sections
were reviewed by two independent observers.
Reagents and culture media T cell proliferation assays were performed
in RPMI 1640 supplemented with 10% fetal bovine serum, 2 mM
glutamine, 1% antibiotic/antimycotic (Gibco, Karlsruhe, Germany), 10 mM
HEPES buffer solution, 1 mM sodium pyruvate, 5 3 10–5 M
2-mercaptoethanol. For fluorescence-activated cell sorting (FACS) analysis,
the monoclonal antibody anti-CD41 (L3T4), anti-CD81 were used, and
anti-rat IgG2aκ (all purchased from PharMingen, San Diego, CA). For
magnetic cell sorting isolation a puffer with 2 mM EDTA and 0.5% bovine
serum albumin (Sigma) was used. Fluorescence-activated cell sorter analysis
was performed to confirm the purity of isolated CD41 and CD81 T cells.
After magnetic cell sorting T cells were stained with anti-CD41 (L3T4),
anti-CD81, and anti-rat IgG2aκ as isotype control (all purchased from
PharMingen) following the instructions of the manufacturer. CD41 T cells
were 97% and CD81 T cells were 80% pure (data not shown).
Preparation of antigen-presenting cells from the spleen Inguinal,
axillary, and brachial lymph nodes were obtained 5 d after in vivo
sensitization. Single cell suspensions from lymph nodes were purified for
CD41 and CD81 T cells by magnetic cell sorting as described by the
supplier (Milteny Biotec, GmbH Bergisch-Gladbach, Germany). CD41 T
cells were plated at 105 cells per well in the presence of 5 3 105 irradiated
(3000 RAD) and 2,4-dinitrobenzoic acid (DNBS)-modified spleen cells as
described by Shearer (1974). T cell lines were restimulated (six to eight
Table I. Primers for RT-PCR were designed by using
sequences obtained from Genbank
GAPDH 59: 59 TCA TGA CCA CAG TCC ATG CCA TCA C 39
GAPDH 39: 59 GCC GTA TTA ATT GTC ATA CCA GGA AAT GA 39
IL-10 59: 59 ATG CAG GAC TTT AAG GGT TAC TTG GGT T 39
IL-10 39: 59 AAT TCG GAG AGA GGT ACA AAC GAG GTT T 39
IL-4 59: 59 ATG GGT CTC AAC CAG CTA GT 39
IL-4 39: 59 GCT CTT TAG GCT TTC CAG GAA GTC 39
times) by adding fresh DNBS-modified irradiated syngeneic stimulator
cells every 10–12 d. T cell proliferation was determined by the incorporation
of [3H]thymidine the last 17 h of culture. Results are presented as the
mean of assays performed in triplicate.
Enzyme-linked immunosorbent assay Cytokine-specific sandwich
enzyme-linked immunosorbent assay for determining quantities of IL-1β,
IL-2, IL-4, interferon-γ, and IL-10 in the supernatants from CD41 and
CD81 cell lines were performed generally following the instructions of
the supplier (Genzyme, Cambridge, MA).
Adoptive transfer experiments Cell suspensions obtained from lymph
nodes of DNCB-sensitized mice were injected into the ears of naı¨ve mice
(five mice per group) (2 3 105 per 20 µl phosphate-buffered saline) as
described previously (Dieli et al, 1994). The mice were immediately
challenged by applying 10 µl 1% DNCB in acetone:olive-oil (4:1) on both
sides of the right ear. In these experiments negative controls were groups
of mice injected with phosphate-buffered saline, s.c., into the ears and
challenged with 1% DNCB as described above. Ear thickness was measured
shortly before challenge and swelling was assessed 12 and 24 h after
challenge with the use of an engineer’s micrometer (Kroeplin, Schluechtern,
Germany) as described.
Reverse transcriptase-polymerase chain reaction (PCR) for IL-4
and IL-10 Total RNA was isolated by the guanidium/thiocyanate/
caesium chloride method. Reverse transcription was performed according
to the manufacturers protocol (Gibco, BRL) using oligo d(T)16 primer.
Primers were synthesized by MWG (Ebersberg, Germany) as shown
in Table I.
The cycling conditions were as follows: denaturation for 1 min at 94°C,
annealing for 1.5 min at 55°C (IL-4, IL-10) and 57°C (GAPDH). Primers,
mRNA concentrations, and PCR cycles were titrated to establish standard
curves to demonstrate linearity that allowed semiquantitative analysis of
signal strength. IL-4 and IL-10 transfected Hy 358 cells were used as
positive controls (kindly provided by Dr. W. Mu¨ller).
After PCR, samples were electrophoresed on agarose gels, blotted and
hybridized to P32 end-labeled oligos (IL-4: 59 AAA ATA TGC GAA GCA
CCT TGG AAG CCC TAC 39; IL-10 59 GCC TTG TAG ACA
CCT TGG TCT TCC AGC TTA 39) or a P32 labeled random primed
GAPDH cDNA probe (kindly provided by Dr. J. Uitto, Thomas Jefferson
University, Philadelphia, PA). After hybridization filters were washed and
exposed at –80°C to a radiosensitive filter.
Statistics The double-tailed Student’s t-test was used to compare the
significance of differences between groups.
RESULTS
Impaired and shortened CHS response to DNCB in the
absence of endogenous IL-4 To evaluate the capacity of IL-
4-deficient mice to develop CHS, 5% DNCB were used for
sensitization on the abdomen and 1% DNCB for challenge on the
right ear 5 d later. The left ear was exposed to the vehicle (acetone/
olive oil) alone. As shown in Fig 1 the time courses of CHS
responses were similar in IL-4-deficient mice and control mice.
Maximum of ear swelling in both mouse strains was observed after
24 h. Notably, ear swelling responses of IL-4-deficient mice were
strongly reduced which exhibited a 40%–60% reduction of ear
swelling after 12 h (p , 0.01) compared with control mice. The
strongest suppression of CHS in IL-4-deficient mice was observed
12–24 h after challenge with DNCB (Fig 1). After 24 h ear
thickness declined in both IL-4-deficient mice and control mice.
Mutant mice showed an ear thickness that was back to baseline
after 8 d whereas the ear thickness of control mice returned to
normal size with a delay of 10 d after challenge.
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Figure 1. Attenuated CHS to DNCB in IL-4-deficient mice. IL-4-
deficient mice and wild-type mice were sensitized with 1% DNCB on day
0 and challenged on the right ear on day 5 with 1% DNCB. The left ear
was treated with vehicle acetone/olive oil alone. The increase of ear
thickness was measured 12 h to 8 d after challenge. Data represent mean
swelling values obtained with six mice per group and are representative of
four independent experiments (statistical significance: p , 0.005) j, wild-
type mice; u, IL-4-deficient mice.
Histologic examination of the challenge and control ears of the
wild-type and IL-4-deficient mice after 24 h revealed a reduced
edema and cellular infiltrate in the mutant mice confirming the
results of the mouse ear swelling test (Fig 2a–d). Furthermore,
ICAM-1 and IA (major histocompatibility complex class II) molec-
ule expression as determined by immunohistochemical staining also
was markedly reduced after 12 and 24 h in the mutant mice
(Fig 2e–j).
In heterozygous IL-4 BALB/C mice (IL-4 1/–) CHS
response to DNCB is similar as in wild-type BALB/C
mice Differing results were recently reported using IL-4-deficient
mice on the genetic background C57BL/6 (Berg et al, 1995;
Weigman et al, 1997). In order to exclude influences of the genetic
background on the diminished CHS response, IL-4-deficient mice
were backcrossed to wild-type BALB/C mice in order to generate
heterozygous IL-4 (1/–) BALB/C mice. When these heterozygous
mice were sensitized and challenged as described above no signific-
ant difference in ear swelling response compared with wild-type
mice was observed in two experiments performed with five mice
per group (data not shown).
Lymph node cells from IL-4-deficient mice fail to induce
CHS in BALB/C mice We analyzed the ability of lymph node
cells of sensitized mice to transfer CHS. Cells were injected
subcutaneously into the ears of naı¨ve mice followed by challenge
with DNCB applied epicutaneously. IL-4-deficient mice were
sensitized with 5% DNCB on the abdomen, 5 d later axillary and
inguinal lymph nodes were taken and processed to single cell
suspensions. Lymph node cells (2 3 105) were injected subcutane-
ously into the ears of naı¨ve BALB/C mice. The same experiment
was performed with lymph node cells of BALB/C mice, which
were injected in IL-4-deficient mice as described above. Challenge
was performed immediately after injection of lymph node cells by
applying 1% DNCB on both sides of the ear. Ear swelling was
measured 12 and 24 h after challenge. As expressed in Fig 3
BALB/C mice failed to exhibit CHS after injection of lymph node
cells of sensitized IL-4-deficient mice. On the other hand IL-4-
deficient mice showed a normal CHS response to DNCB after
injection of lymph node cells of sensitized BALB/C mice.
The CHS response to oxazolone is not impaired in IL-4-
deficient mice To evaluate the CHS reaction to oxazolone, a less
potent allergen inducing both a T cell response and immunoglobulin
response, we sensitized IL-4-deficient (IL-4 –/–) and BALB/C
wild-type mice (IL-4 1/1) with 5% oxazolone. Five days later,
mice were challenged with 1% oxazolone and ear swelling was
measured as described above. Although mutant mice showed a
reduced CHS response in comparison to wild-type BALB/C mice
the difference was not significant (Fig 4). These results are in
agreement with previous investigations showing a normal CHS
reaction in IL-4-deficient C57BL/6 mice to Oxazolone (Berg
et al, 1995).
IL-10 mRNA is not induced during the CHS response to
DNCB in IL-4-deficient BALB/C mice but in CHS response
to oxazolone In order to confirm that IL-4 is adequately induced
under the experimental conditions used, semiquantitative reverse
transcriptase-PCR for IL-4 was performed. After sensitization with
5% DNCB mice were challenged with 1% DNCB on the right
ear. The left ear was exposed to vehicle alone. Twenty-four hours
after challenge mice were killed and ears taken for RNA extraction.
As shown in Fig 5(A) (lane 2) there is a strong induction of IL-4
mRNA in wild-type mice after 24 h. As expected IL-4 mRNA
induction in IL-4-deficient mice (IL-4 –/–) is lacking (Fig 5A,
lane 4).
IL-10 has previously been shown to be involved in the natural
negative control of CHS responses in the skin (Enk et al, 1993).
Recent studies have shown that after application of an allergen,
IL-10 mRNA is rapidly upregulated with a peak at 12 h returning
to normal levels thereafter (Ferguson et al, 1994). Therefore, IL-
10 mRNA levels were determined to investigate the role of IL-10
expression in the attenuated CHS response of IL-4-deficient mice.
Interestingly, IL-10 mRNA levels were strongly induced after 12 h
only in the wild-type mice (Fig 5C, lane 2), whereas no such
induction could be detected in the mutant mice (Fig 5C, lane 4)
indicating that local up-regulation of IL-10 is not responsible for
the reduced CHS response in IL-4-deficient mice. In contrast 12 h
after challenge to oxazolone induction of IL-10 mRNA was
observed both in control and IL-4-deficient mice (Fig 5E, lanes 2
and 4).
Normal proliferative capacity of CD41 and CD81 T cells in
IL-4-deficient mice In order to evaluate whether an altered
proliferation behavior of CD41 and CD81 T cells plays a part in
the reduced CHS response, T cell proliferation assays were per-
formed. In vivo 5% DNCB-sensitized mice were killed and reactive
axillary and inguinal lymph nodes were obtained. Single cell
suspensions from these lymph nodes were separated for CD41 and
CD81 T cells by magnetic cell sorting. Pure CD41 and CD81 T
cells controlled by fluorescence-activated cell sorter were incubated
with syngeneic irradiated and DNBS-modified spleen cells. Prolif-
eration activity was measured by the incorporation of [3H]thymidine
the last 17 h of culture. Proliferation indices of CD41 and CD81
T cells from IL-4 (1/1) and IL-4 (–/–) mice were similar. CD41
and CD81 T cell lines derived from IL-4 (1/1) and IL-4 (–/–)
mice were highly specific for the antigen DNBS indicating that
IL-4-deficient mice show normal antigen specific T cell prolifera-
tion (data not shown).
Differential induction of IL-10 synthesis by immune CD41
and CD81 T cells of IL-4 (–/–) and IL-4 (1/1) mice after
hapten sensitization As the results of ear swelling tests showed
an attenuation of the CHS response in IL-4-deficient mice and
antigen-specific proliferation capacity of T cells was unchanged,
hapten-immune CD41 and CD81 T cells were stimulated by
culture with syngeneic DNBS modified spleen cells. Cytokine
profiles produced by CD41 and CD81 T cells from in vivo DNCB-
sensitized mice were analyzed from the culture supernatants of the
cells. IL-4 production was not observed in CD41 IL-4 (–/–) T cells,
as predicted, whereas IL-4 production of control CD41 T cells
reached a maximum 12 h after in vitro restimulation with DNBS.
Forty-eight hours after stimulation the IL-4 concentration declined
and went to nondetectable levels after 144 h (Fig 6b). IL-2
production of CD41 T cells from both mouse strains were similar
as were IL-1α and IL-1β concentrations (data not shown). Analysis
of the cytokine production of CD81 cells revealed, however, that
VOL. 112, NO. 4 APRIL 1999 ALLERGIC CONTACT DERMATITIS IN INTERLEUKIN-4 DEFICIENT MICE 479
F
ig
u
re
2.
H
is
to
lo
g
ic
an
al
ys
is
o
f
th
e
C
H
S
re
sp
o
n
se
in
IL
-4
d
efi
ci
en
t
m
ic
e.
C
el
lu
la
r
in
fil
tr
at
e
an
d
ed
em
a
is
re
du
ce
d
in
IL
-4
-d
efi
ci
en
t
m
ic
e
(A
–D
)
an
d
ac
co
m
pa
ni
ed
by
de
cr
ea
se
d
H
LA
cl
as
s
II
(E
–G
)
an
d
IC
A
M
-1
ex
pr
es
sio
n
24
h
af
te
r
ch
al
le
ng
e
(H
–J
).
H
ist
ol
og
ic
an
al
ys
is
of
th
e
C
H
S
re
sp
on
se
:
(A
)
w
ild
-t
yp
e
ea
r,
un
ch
al
le
ng
ed
(B
),
w
ild
-t
yp
e
ea
r
24
h
af
te
r
ch
al
le
ng
e
w
ith
1%
D
N
C
B
.
E
ar
th
ic
ke
ni
ng
is
du
e
to
ed
em
a
an
d
in
fil
tr
at
io
n
of
in
fla
m
m
at
or
y
ce
lls
,
(C
)
IL
-4
-d
efi
ci
en
t
m
ic
e
ea
r,
un
ch
al
le
ng
ed
,
(D
)
IL
-4
-d
efi
ci
en
t
m
ic
e
ea
r,
24
h
af
te
r
ch
al
le
ng
e
w
ith
1%
D
N
C
B
.
A
m
od
er
at
e
ed
em
a
an
d
a
lo
w
er
ce
llu
la
r
in
fil
tr
at
e
as
in
w
ild
-t
yp
e
m
ic
e
le
ad
s
to
th
e
re
du
ce
d
ea
r
th
ic
kn
es
s.
Im
m
un
oh
ist
oc
he
m
ist
ry
fo
r
H
LA
cl
as
s
II
:
(E
)
w
ild
-t
yp
e
ea
r
un
ch
al
le
ng
ed
(m
ut
an
t
ea
r
no
t
sh
ow
n)
;
(F
)
w
ild
-t
yp
e
ea
r
24
h
af
te
r
ch
al
le
ng
e
w
ith
1%
D
N
C
B
;
(G
)
IL
-4
-d
efi
ci
en
t
m
ic
e
ea
r
24
h
af
te
r
ch
al
le
ng
e,
no
te
th
e
re
du
ce
d
ed
em
a
an
d
in
fil
tr
at
e
ac
co
m
pa
ni
ed
by
de
cr
ea
se
d
st
ai
ni
ng
fo
r
H
LA
cl
as
s
II
in
th
e
in
fil
tr
at
e.
Im
m
un
oh
ist
oc
he
m
ist
ry
fo
r
IC
A
M
-1
:
(H
)
w
ild
-t
yp
e
ea
r
un
ch
al
le
ng
ed
(m
ut
an
t
ea
r
no
t
sh
ow
n)
;
(I
)
w
ild
-t
yp
e
ea
r
24
h
af
te
r
ch
al
le
ng
e
w
ith
1%
D
N
C
B
;
(J
)
IL
-4
-d
efi
ci
en
t
m
ic
e
ea
r
24
h
af
te
r
ch
al
le
ng
e,
pl
ea
se
no
te
th
e
re
du
ce
d
ed
em
a
an
d
in
fil
tr
at
e
ac
co
m
pa
ni
ed
by
de
cr
ea
se
d
st
ai
ni
ng
fo
r
IC
A
M
-1
.
Sc
al
e
ba
r:
40
µm
.
480 TRAIDL ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
Figure 3. Lymph node cells from interleukin-4 deficient mice fail
to induce CHS in BALB/C mice Adoptive transfer experiments were
performed: lymph node cells from sensitized mutant mice were injected
subcutaneously into the ears of BALB/C mice and vice versa. Mice were
challenged immediately after injection of lymph node cells with 1% DNCB.
Data represent mean swelling values obtained after 12 h with five mice
per group and are representative of two independent experiments (statistical
significance: p , 0.02). (A) Lymph node cells of sensitized IL-4-deficient
mice fail to mediate CHS in BALB/C mice. (B) Lymph node cells from
wild-type mice mediate CHS in IL-4-deficient mice. As a control is shown
ear swelling after sensitization of wild-type mice (C) and IL-4 mutant
mice (D).
Figure 4. CHS to oxazolone is not reduced in IL-4-deficient mice.
Control mice (BALB/C) and IL-4-deficient mice were sensitized with 1%
oxazolone on the right ear and vehicle alone on the left ear. Ear swelling
was measured after 10 and 24 h. Results are presented as the difference of
the ear thickness right and left to each time point. (–/–) IL-4-deficient
mice; (1/1): control mice.
IL-4-deficient CD81 T cells produced significantly more IL-10
than cells obtained from control mice (Fig 6a).
DISCUSSION
The duration and magnitude of the CHS response depend on cell–
cell interactions, which are generally mediated by a direct contact
via receptor–ligand interactions and indirect signaling via cytokines
or growth factors. Concerning the role of IL-4 in CHS contradicting
results have been obtained (Gautam et al, 1992; Salerno et al, 1995;
Asada et al, 1997) supporting an anti-inflammatory as well as a
proinflammatory function of IL-4. While Gautam et al (1992)
demonstrated that injection of recombinant IL-4 protein inhibits the
elicitation phase and treatment of mice with anti-IL-4 monoclonal
antibody augmented the CHS response, Salerno et al (1995)
observed that the treatment of lymph node cells with anti-
sense oligonucleotides to IL-4 inhibited the transfer of CHS to
recipient mice.
Our study aimed to analyze the role of endogenous IL-4 in
CHS using transgeneic mice lacking IL-4 expression. Therefore,
we induced CHS in BALB/C mice bearing a germline mutation
in the IL-4 gene using two different obligate contact allergens:
Figure 5. Lack of IL-10 mRNA induction in the CHS response of
IL-4-deficient mice. Mice sensitized with 5% DNCB were challenged
with 1% DNCB on the right ear and vehicle alone on the left ear. Lane
1, wild-type mice control (i.e., left ear exposed to vehicle alone); lane 2,
wild-type mice challenge (i.e., right ear challenged with 1% DNCB
(A–D) or oxazolone (E, F); lane 3, IL-4-deficient mice control (i.e., left
ear exposed to vehicle alone); lane 4, IL-4-deficient mice challenge (i.e.,
right ear challenged with 1% DNCB (A–D) or oxazolone (E, F); lane 5,
positive control consisting of RNA extracted from Hy 358 cells transfected
with the murine IL-4 gene (A, B) and IL-10 gene (C–F). (A) IL-4 mRNA
expression was assessed 24 h after challenge confirming a strong induction
of IL-4 mRNA expression in wild-type mice (lane 2), and no expression
in IL-4-deficient mice (lane 4). (B) GAPDH mRNA expression is shown
as a control. (C) IL-10 mRNA expression was determined after 12 h
showing a strong induction in the control mice (lane 2), whereas this
induction is lacking in the IL-4 deficient mice (lane 4). (D) GAPDH
mRNA expression is shown as a control. (E) IL-10 mRNA expression is
both induced in control mice (lane 2) and mutant mice (lane 4) after
challenge with 1% oxazolone. (F) GAPDH mRNA expression is shown
as a control. The blots are representative of three independent experiments.
PCR for each cytokine was carried out at least three times
DNCB and oxazolone. CHS was measured quantitatively by using
the classic parameter of contact dermatitis, the ear swelling test (Gad
et al, 1986). Previously, Berg et al (1995) reported a nonsignificant
reduction of the CHS to oxazolone in IL-4-deficient mice on the
C57BL/6 background, which is known to be a low responder in
CHS (Shultz and Baily, 1975). Weigmann et al (1997) observed a
significant reduction of CHS in the late phase (up to day 3 after
challenge) of the CHS response using DNFB as the allergen in the
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Figure 6. Differential induction of cytokine synthesis after hapten
sensitization. (A) Higher concentrations of IL-10 measured in supernatants
of CD81 T cell lines from IL-4-deficient mice when compared with
control mice (p , 0.02). (B) Concentration of IL-4 in supernatants of
DNBS-specific CD41 cell lines from IL-4-deficient and wild-type mice:
maximal production of IL-4 of CD41 IL-4 (1/1) T cells 1 d after
restimulation with DNBS modified spleen cells. No detectable IL-4 in
supernatants of T cell lines from deficient mice. Data represent mean
concentration values obtained from supernatants from five wells each and
are representative of two independent experiments.
same strain (C57BL/6). BALB/C mice, however, which have a
different genetic restriction and are widely used to investigate CHS
reactions, were not yet analyzed. This mouse strain is known as a
high responder in contact dermatitis (Shultz et al, 1975).
Using DNCB as the sensitizing allergen, the time course of CHS
in BALB/C mutant mice and control mice was characteristic for a
CHS response with maximum ear swelling after 24 h. This indicates
that contact dermatitis can be induced in mutant BALB/C mice
lacking IL-4 expression. Direct comparison of the intensity of the
ear swelling response of mutant and control mice, however, revealed
that mutant mice showed a significantly attenuated and shortened
CHS response from 12 to 194 h after challenge. Histologic
examination of the ears revealed that the impaired CHS response
in IL-4-deficient mice measured by the mouse ear swelling test
was accompanied by decreased cellular infiltrate and edema in the
challenged ear. The reduced cellular infiltrate was also accompanied
by a diminished induction of ICAM-1 and major histocompatibility
complex class II molecules, which could in part be due to the
lacking action of IL-4, as this cytokine has previously been shown
to induce these molecules (Masinovsky et al, 1990; Galea et al, 1993).
The attenuated CHS response in the IL-4-deficient mice was
restored to normal levels in heterozygous mice excluding an
influence of the genetic background. These findings do not support
an inhibitory role of IL-4 in the CHS response to DNCB but
rather a proinflammatory, as both magnitude and duration of the
CHS response were significantly diminished in the IL-4-deficient
mice. As our results differ from the observations of Berg et al (1995)
the question arose whether the allergens (oxazolone, DNCB)
applied or the genetic background is responsible for this discrepancy.
Therefore, additional experiments were performed using oxazolone
as the sensitizing agent. Notably, as in the C57BL/6 strain, no
difference in the ear swelling response compared with wild-type
mice was observed. Thus, our results extend the observations of
Berg et al (1995) suggesting that the CHS response to oxazolone
and DNCB evolves on different pathways independent and depend-
ent on IL-4. Similar results have recently been obtained by Shornick
et al (1996) and Zengh et al (1995). These authors reported
that IL-1β-deficient mice exhibited a differential response to
trinitrochlorobenzene (TNCB) and oxazolone. A normal CHS
response to oxazolone was found, whereas a defective CHS response
to low doses of TNCB could be restored using high doses of the
sensitizing antigen. Therefore, one may speculate that more than
one type of CHS exists or rather different agents induce different
immunologic pathways and cytokine cascades. This has already
been implicated for irritants (Willis et al, 1993; Willmer et al, 1994;
Grangsjo et al, 1996).
To investigate whether an impaired antigen-specific proliferation
is responsible for the attenuated CHS in IL-4-deficient mice
proliferation assays of CD41 and CD81 T cells were performed.
These experiments revealed that antigen-specific proliferation of
CD41 and CD81 T cells is unaltered in the absence of endogenous
IL-4. Weigmann et al (1997) showed that the antigen presentation
of Langerhans cells in IL-4-deficient mice is unaltered suggesting
that neither an impaired proliferation capacity of T cells nor an
impaired antigen presentation from Langerhans cells to T cells is
responsible for the reduction of CHS in IL-4-deficient mice. The
analysis of the supernatants of antigen-specific CD41 and CD81
T cells from IL-4-deficient and control mice revealed a differential
pattern of cytokine synthesis. Although IL-2 and IL-1β production
was similar in IL-4 1/1 and IL-4 –/– mice, supernatants from
CD81 cells in IL-4-deficient mice showed higher IL-10 concentra-
tions, whereas in mice on a different genetic background (Kopf
et al, 1993) a deficiency of IL-10 synthesis had been observed.
Interestingly, adoptive transfer experiments revealed that no CHS
response could be elicited when lymph node cells from sensitized
IL-4-deficient mice were injected into the ears of control mice.
This indicates that IL-4 is an important constituent of the cytokine
milieu during the early effector phase, as it has been previously
suggested by the studies of Salerno et al (1995). Further studies are
needed, however, e.g., by reconstituting IL-4 in the mutant mice,
to examine its exact role further.
The reduced ear swelling and inflammatory response after
challenge with 1% DNCB is accompanied by a lack of IL-10
mRNA expression in IL-4-deficient mice. This indicates that
overproduction of IL-10 in the ear skin, which is thought to be
predominantly produced by keratinocytes (Ferguson et al, 1994), is
not responsible for the diminished CHS response. The lacking
induction of IL-10 in IL-4-deficient mice rather reflects the largely
reduced inflammatory reaction after challenge with DNCB, as IL-
10 is normally induced after challenge with oxazolone. Although
an induction of other inhibitory cytokines cannot be excluded, our
results further provide strong evidence for a direct proinflammatory
activity of IL-4 during the early phase of CHS response as proposed
by other authors (Mu¨ller et al, 1993; Trepper, 1994; Salerno
et al, 1995).
In summary this study shows that, unexpectedly, a loss of
endogenously produced IL-4 leads to a significant reduction of the
magnitude and duration of the CHS response to DNCB supporting
an important proinflammatory function of this cytokine. The
normal CHS response to oxazolone in IL-4-deficient mice suggests,
however, that this proinflammatory role depends on the chemical
compound used to elicit the CHS response.
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